Efficacy and safety of Infliximab in systemic sarcoidosis according to GenPhenReSa organ-involvement phenotype: a retrospective study of 55 patients

被引:0
|
作者
Etienne Rivière
Wendy Jourde
Noémie Gensous
Xavier Demant
Emmanuel Ribeiro
Pierre Duffau
Patrick Mercié
Jean-François Viallard
Estibaliz Lazaro
机构
[1] University Hospital Centre of Bordeaux,Internal Medicine and Infectious Diseases unit, Haut
[2] INSERM U1034,Leveque Hospital
[3] Bordeaux University,Department of Internal Medicine and Clinical Immunology, Saint Andre Hospital
[4] University Hospital Centre of Bordeaux,ImmunoconcEpT; FHU ACRONIM
[5] UMR CNRS 5164,Respiratory Diseases unit, Haut
[6] Bordeaux University,Leveque Hospital
[7] University Hospital Centre of Bordeaux,undefined
[8] Univ. Bordeaux,undefined
[9] INSERM,undefined
[10] BRIC,undefined
来源
Respiratory Research | / 25卷
关键词
Sarcoidosis; Infliximab; Disease clusters; Infection;
D O I
暂无
中图分类号
学科分类号
摘要
Infliximab is highly effective in patients with CNS (group 1) and liver (group 2) organ-predominant sarcoidosis.
引用
收藏
相关论文
共 4 条
  • [1] Efficacy and safety of Infliximab in systemic sarcoidosis according to GenPhenReSa organ-involvement phenotype: a retrospective study of 55 patients
    Riviere, Etienne
    Jourde, Wendy
    Gensous, Noemie
    Demant, Xavier
    Ribeiro, Emmanuel
    Duffau, Pierre
    Mercie, Patrick
    Viallard, Jean-Francois
    Lazaro, Estibaliz
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [2] Efficacy and safety of CT-P13, a biosimilar of infliximab, in patients with inflammatory bowel disease: A retrospective multicenter study
    Jung, Yoon Suk
    Park, Dong Il
    Kim, Young Ho
    Lee, Ji Hyun
    Seo, Pyoung Ju
    Cheon, Jae Hee
    Kang, Hyoun Woo
    Kim, Ji Won
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (12) : 1705 - 1712
  • [3] Long-term efficacy and safety of CT-P13, a biosimilar of infliximab, in patients with inflammatory bowel disease: A retrospective multicenter study
    Kim, Nam Hee
    Lee, Ji Hyun
    Hong, Sung Noh
    Yoon, Hyuk
    Kang, Hyoun Woo
    Lee, Suck-Ho
    Im, Jong Pil
    Cha, Jae Myung
    Eun, Chang Soo
    Kim, Ji Won
    Choi, Chang Hwan
    Park, Dong Il
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (09) : 1523 - 1532
  • [4] Long-term efficacy and safety of CT-P13, a biosimilar of infliximab, in patients with inflammatory bowel disease: A retrospective multicenter study
    Kim, Nam Hee
    Park, Dong Il
    Kim, You Sun
    Eun, Chang Soo
    Cha, Jae Myung
    Hong, Sung Noh
    Jang, Byung Ik
    Kim, Ji Won
    Kim, Duk Hwan
    Kang, Hyoun Woo
    Choi, Chang Hwan
    Kim, Eun Sun
    Im, Jong Pil
    Yoon, Hyuk
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 479 - 479